Elucidating the targets of antileukemic agents: Molecular mechanisms of mercaptopurine action

Molecular Biology

Volumn 34, Issue 6, 2000, Pages 895-901

  Krynetskaia, N F ^a,c   Krynetski, E Y ^b,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Heteroduplex; Mercaptopurine; Modified DNA; Ribonuclease H; Thioguanosine; Thiopurine S methyltransferase

Indexed keywords

EID: 0034309934     PISSN: 00268933     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026683927519     Document Type: Article

References (47)

1. Elion, G.B., Science, 1989, vol. 24, pp. 441-447.
2. Pui, C.H. and Evans, W.E., N. Engl. J. Med., 1998, vol. 339, pp. 605-615.
3. Evans, W.E. and Relling, M.V., Science, 1999, vol. 286, 487-491.
4. Evans, W.E., Horner, M., Chu, Y.Q., Kalwinsky, D., and Roberts, W.M., J. Pediatr., 1991, vol. 119, pp. 985-989.
5. Lennard, L., Gibson, B.E., Nicole, T., and Lilleyman, J.S., Arch. Dis. Child., 1993, vol. 69, pp. 577-579.
6. Schutz, E., Gummert, J., Mohr, F., and Oellerich, M., Lancet, 1993, vol. 341, pp. 436-436.
7. LePage, G.A., Cancer Research, 1963, vol. 23, pp. 1202-1206.
8. Maybaum, J. and Mandel, H.G., Cancer Research, 1983, vol. 43, pp. 3852-3856.
9. Krynetski, E.Y., Tai, H.L., Yates, C.R., Fessing, M.Y., Loennechen, T., Schuetz, J.D., Relling, M.V., and Evans, W.E., Pharmacogenetics, 1996, vol. 6, pp. 279-290.
10. Krynetski, E.Y., Krynetskaia, N.F., Yanishevski, Y., and Evans, W.E., Mol. Pharmacol., 1995, vol. 47, pp. 1141-1147.
11. Pieters, R., Huismans, D.R., Loonen, A.H., Peters, G.J., Hahlen, K., Van Der Does-Van Den Berg, A., Van Wering, E.R., and Veerman, A.J., Int. J. Cancer, 1992, vol. 51, pp. 213-217.
12. Lennard, L., Keen, D., and Lilleyman, J.S., Clin. Pharmacol. Ther., 1986, vol. 40, pp. 287-292.
13. Krynetski, E.Y. and Evans, W.E., Am. J. Hum. Genet., 1998, vol. 63, pp. 11-16.
14. Krynetski, E.Y. and Evans, W.E., Pharmaceutical Research, 1999, vol. 16, pp. 342-349.
15. Tai, H.L., Krynetski, E.Y., Yates, C.R., Loennechen, T., Fessing, M.Y., Krynetskaia, N.F., and Evans, W.E., Am. J. Hum. Genet., 1996, vol. 58, pp. 694-702.
16. Szumlanski, C., Otterness, D., Her, C., Lee D., Brandriff, B., Kelsell, D., Spurr, N., Lennard, L., Wieben, E., and Weinshilboum, R., DNA Cell Biol., 1996, vol. 15, pp. 17-30.
17. Otterness, D., Szumlanski, C., Lennard, L., Klemetsdal, B., Aarbakke, J., Park-Hah, J.O., Iven, H., Schmiegelow, K., Branum, E., and O'Brien, J., Clin. Pharmacol. Ther., 1997, vol. 62, pp. 60-73.
18. Otterness, D.M., Szumlanski, C.L., Wood, T.C., and Weinshilboum, R.M., J. Clin. Invest., 1998, vol. 101, pp. 1036-1044.
19. Loennechen, T., Yates, C.R., Fessing, M., Relling, M.V., Krynetski, E.Y., and Evans, W.E., Clin. Pharmacol. Ther., 1998, vol. 64, pp. 46-51.
20. Spire-Vayron d. l. M., C., Debuysere, H., Sabbagh, N., Marez, D., Vinner, E., Chevalier, E.D., Lo Guidice, J.M., and Broly, F., Human Mutation, 1998, vol. 2, pp. 177-185.
21. Hon, Y.Y., Fessing, M., Pui, C.H., Relling, M.V., Krynetski, E. Y., and Evans, W.E., Human Mol. Genet., 1999, vol. 8, pp. 371-376.
22. Yates, C.R., Krynetski, E.Y., Loennechen, T., Fessing, M.Y., Tai, H.L., Pui, C.H., Relling, M.V., and Evans, W.E., Ann. Intern. Med., 1997, vol. 126, pp. 608-614.
23. Spire-Vayron d. l. M., C., Debuysere, H., Sabbagh, N., Marez, D., Vinner, E., Chevalier, E.D., Lo Guidice, J.M., and Broly, F., Human Mutation, 1998, vol. 12, pp. 177-185.
24. Remy, C.N., J. Biol. Chem., 1963, vol. 238, pp. 1078-1084.
25. Remy, C.N., Biochim. Biophys. Acta, 1967, vol. 138, pp. 258-275.
26. Krynetski, E.Y., Fessing, M.Y., Yates, C.R., Sun, D., Schuetz, J.D., and Evans, W.E., Pharmaceut. Res., 1997, vol. 14, pp. 1672-1678.
27. Krynetski, E.Y., Tai, H.L., Yates, C.R., Fessing, M.Y., Loennechen, T., Schuetz, J.D., Relling, M.V., and Evans, W.E., Pharmacogenetics, 1996, vol. 6, pp. 279-290.
28. Lee, D., Szumlanski, C., Houtman, J., Honchel, R., Rojas, K., Overhauser, J., Wieben, E.D., and Weinshilboum, R.M., Drug Metab. Dispos., 1998, vol. 23, pp. 398-405.
29. Fessing, M., Krynetski, E.Y., Zambetti, G.P., and Evans, W.E., Eur. J. Biochem., 1998, vol. 256, pp. 510-517.
30. Spire-Vayron d. l. M., C., Debuysere, H., Mastain, B., Vinner, E., Marez, D., Lo Guidice, J.M., Chevalier, D., Brique, S., Motte, K., and Colombel, J.F., Brit. J. Pharmacol., 1998, vol. 125, pp. 879-887.
31. Spire-Vayron d. l. M., C., Debuysere, H., Fazio, F., Sergent, E., Bernard, C., Sabbagh, N., Marez, D., Lo Guidice, J.M., and D'halluin, J.C., Pharmacogenetics, 1999, vol. 9, pp. 189-198.
32. Krynetski, E.Y. and Evans, W.E., Anticancer Drug Toxicity, Lipp, H.P., Ed., New York: Marcel Dekker, 1999, pp. 392-429.
33. Ling, Y.H., Nelson, J.A., Farquhar, D., and Beattie, K.L., Nucleosides Nucleotides, 1992, vol. 11, pp. 23-35.
34. Maybaum, J. and Mandel, H.G., Exp. Cell Res., 1981, vol. 135, pp. 465-468.
35. Bambara, R.A., Murante, R.S., and Henricksen, L.A., J. Biol. Chem., 1997, vol. 272, pp. 4647-4650.
36. Krynetskaia, N.F., Krynetski, E.Y., and Evans, W.E., Mol. Pharmacol., 1999, vol. 56, pp. 841-848.
37. Schmidt, S., Niemann, A., Krynetskaia, N.F., Oretskaya, T.S., Metelev, V.G., Suchomlinov, V.V., Shabarova, Z.A., and Cech, D., Biochim. Phiphys. Acta, 1992, vol. 1130, pp. 41-46.
38. Krynetskaya, N.F., Metelev, V.G., Tashlitski, V.N., Sukhomlinov, V.V., and Shabarova, Z.A., Nucleic Acid Symp. Ser., 1991, p. 268.
39. Alekseev, Y.I., Krynetskaia, N.F., Tashlitsky, V.N., Oretskaya, T.S., Dolinnaya, N.G., Morvan, F., Rayner, B., Malvy, C., and Shabarova, Z.A., Nucleosides Nucleotides, 1996, vol. 15, pp. 1545-1558.
40. Crouch, R.J., The New Biologist, 1990, vol. 2, pp. 771-777.
41. Wintersberger, U., Pharmac. Ther., 1990, vol. 48, pp. 259-280.
42. Yang, W., Hendrickson, W.A., Crouch, R.J., and Satow, Y., Science, 1990, vol. 249, pp. 1398-1405.
43. Frank, P., Albert, S., Cazenave, C., and Toulme, J.J., Nucleic Acids Res., 1994, vol. 22, pp. 5247-5254.
44. Giles, R.V., Spiller, D.G., and Tidd, D.M., Antisense Res. Dev., 1995, vol. 5, pp. 23-31.
45. Eder, P.S. and Walder, J.A., J. Biol. Chem., 1991, vol. 266, pp. 6472-6479.
46. Marathias, V.M., Sawicki, M.J., and Bolton, P.H., Nucleic Acids Res., 1999, vol. 27, pp. 2860-2867.
47. Nelson, D.M., Butters, K.A., Markert, M.L., Reinsmoen, N.L., and McIvor, R.S., J. Immunol., 1995, vol. 154, pp. 3006-3014.